155 related articles for article (PubMed ID: 30622320)
1. High expression of UBE2T predicts poor prognosis and survival in multiple myeloma.
Zhang W; Zhang Y; Yang Z; Liu X; Yang P; Wang J; Hu K; He X; Zhang X; Jing H
Cancer Gene Ther; 2019 Nov; 26(11-12):347-355. PubMed ID: 30622320
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
7. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
9. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
10. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
11. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
[TBL] [Abstract][Full Text] [Related]
12. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.
Machida YJ; Machida Y; Chen Y; Gurtan AM; Kupfer GM; D'Andrea AD; Dutta A
Mol Cell; 2006 Aug; 23(4):589-96. PubMed ID: 16916645
[TBL] [Abstract][Full Text] [Related]
13. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.
Perez-Peña J; Corrales-Sánchez V; Amir E; Pandiella A; Ocana A
Sci Rep; 2017 Dec; 7(1):17530. PubMed ID: 29235520
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T.
Ramaekers CH; van den Beucken T; Meng A; Kassam S; Thoms J; Bristow RG; Wouters BG
Radiother Oncol; 2011 Oct; 101(1):190-7. PubMed ID: 21722982
[TBL] [Abstract][Full Text] [Related]
18. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription.
Li L; Liu J; Huang W
Dig Liver Dis; 2022 Jul; 54(7):937-945. PubMed ID: 34583905
[TBL] [Abstract][Full Text] [Related]
19. UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma.
Xu N; Cui Y; Shi H; Guo G; Sun F; Jian T; Rao H
Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):20. PubMed ID: 35980647
[TBL] [Abstract][Full Text] [Related]
20. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]